BIOMERICA INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
BIOMERICA INC (BMRA) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $12.00 thousand as of 2026-05-31, per its 10-K filed 2026-08-31.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2026-08-31
- 2026-05-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $12.00K.
- 2025-05-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $18.00K.
- 2024-05-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $0.00.
- 2023-05-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $146.00K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value |
|---|---|
| 2026-05-31 | $12.00K 10-K · filed 2026-08-31 |
| 2025-05-31 | $18.00K 10-K · filed 2026-08-31 |
| 2024-05-31 | $0.00 10-K · filed 2025-08-29 |
| 2023-05-31 | $146.00K 10-K · filed 2025-08-29 |
| 2022-05-31 | $1.84M 10-K · filed 2024-08-28 |
| 2021-05-31 | $2.13M 10-K · filed 2023-08-25 |
| 2019-05-31 | $808.00K 10-K · filed 2019-08-29 |
| 2018-05-31 | $2.75M 10-K · filed 2019-08-29 |
| 2017-05-31 | $1.35M 10-K · filed 2018-08-29 |
| 2016-05-31 | $952.00K 10-K · filed 2017-08-29 |
| 2015-05-31 | $376.00K 10-K · filed 2016-08-29 |
| 2014-05-31 | $325.00K 10-K · filed 2015-08-31 |
| 2013-05-31 | $353.00K 10-K · filed 2014-08-29 |
| 2012-05-31 | $232.00K 10-K · filed 2013-08-29 |
| 2011-05-31 | $23.00K 10-K · filed 2012-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |